Is you
New South Wales: innovation and collaboration New South Wales is a crucial player in Australia’s clinical trial landscape. Through clinicaltrialsNSW, the state offers tailored support, connecting sponsors, investigators, trial sites, and patient populations; and a process to review clinical trials units for quality. NSW’s diverse population, concentrated healthcare network, and advanced infrastructure make it an ideal location for complex and large-scale studies.
NSW’s Collaborative Network Sydney is home to numerous renowned medical research institutions, including the Children’s Medical Research Institute and the Garvan Institute of Medical Research, as well as a network of Health and Innovation Precincts with strong experience delivering clinical trials. The Sydney Children’s Hospitals Network (SCHN)
is Australia’s largest children’s healthcare provider. It hosts dedicated clinical research facilities designed to facilitate the conduct of clinical research in a space that accommodates the needs of young patients and families. Recent trials have seen SCHN be the first international recruitment site open for novel gene therapies, the trialling of re-purposed medications for paediatric brain tumours, trials of dietary modifications improving quality of life for children with multi-system genetic conditions, and the use of cannabinoid therapy for children living with incurable neurodevelopmental disorders.
Queensland: a state of excellence Queensland supports clinical trial excellence through its centralised Queensland Clinical Trials Coordination Unit, a concierge service for sponsors. The unit assists with regulatory navigation and site selection. Queensland’s commitment to expanding access to regional and remote areas positions it as a leader in inclusive trial design. The Queensland Clinical Trials Portal facilitates easy searching for sites and service providers. At the same time, the Queensland Clinical Trials Consortium showcases a strong collaboration between government, industry, and academia to meet trial needs. Over $1bn in clinical trials investment has occurred in over the last five years. Omico’s Precision Oncology Screening
Platforms Enabling Clinical Trials (PrOSPeCT) initiative is revolutionising cancer care by providing free comprehensive genomic profiling to 23,000
OYO241125_A5-US-Ad_PP.indd 1 Outsourcing in Clinical Trials Handbook | 53
Australians with advanced, incurable, or poor- prognosis cancers. Patients are matched to biomarker-led clinical trials, driving innovation in oncology research. To date, over 10,000 Australians have been
referred with 75% identified as having actionable biomarkers. The initiative supports 61 (and growing) company-sponsored precision oncology trials, 16 of which would not have launched in Australia without PrOSPeCT. Omico aims to involve one in four Australian
clinica Aust
IN PARTNERSHIP Australia is recognised glob
cancer patients in clinical trials within five years, a leap from the current one in ten. Zero Childhood Cancer (ZERO) is a world- leading precision medicine program for children with cancer. Jointly led by Children’s Cancer Institute and Kids Cancer Centre, at Sydney Children’s Hospital, Randwick, ZERO involves over 150 scientists and clinicians working together across all 9 Australian and 2 New Zealand paediatric oncology centres. ZERO employs advanced precision medicine techniques, including comprehensive genomic profiling, to identify genetic cancer drivers and recommend personalised treatment options. Since 2017, over 2000 children have been enrolled. ZERO has significantly improved clinical
outcomes, changing the model of care in Australia for high-risk and undiagnosable patients (Lau et al. Nature Medicine 2024). ZERO expanded access to all children with cancer in November 2023 (~1000 children per year). This world-leading platform and associated datasets, preclinical models and clinical networks can support paediatric development plan data requirements and makes Australia an attractive place to run paediatric oncology clinical trials.
FOR FURTHER INFORMATION AND CONTACT DETAILS, SCAN THIS QR CODE:
Brought to you by
continues to bolster capacity regional, rural and remote l bridging the gap between m
services by leveraging telecom decentralised par
Key
Fast and flexible regulatory system
Competitive costs and financial incentives
Globally recognised data standards
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
